Figure 1.

Standard WHO strategy for drug-treatment-based schistosomiasis control

Treatment is targeted to the entire population of children aged 5–14 years, but to limit adverse reactions, children who are acutely ill are excluded. Coverage levels are estimated after each cycle of treatment.¹²